Capricor Therapeutics, Inc.

NasdaqCM:CAPR Rapporto sulle azioni

Cap. di mercato: US$839.4m

Capricor Therapeutics Gestione

Gestione criteri di controllo 4/4

Capricor Therapeutics Il CEO è Linda Marbán, nominato in Jan2010, e ha un mandato di 14.83 anni. la retribuzione annua totale è $ 747.32K, composta da 29.5% di stipendio e 70.5% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.44% delle azioni della società, per un valore di $ 3.68M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 12.7 anni e 11 anni.

Informazioni chiave

Linda Marbán

Amministratore delegato

US$747.3k

Compenso totale

Percentuale dello stipendio del CEO29.5%
Mandato del CEO14.8yrs
Proprietà del CEO0.4%
Durata media del management12.7yrs
Durata media del Consiglio di amministrazione11yrs

Aggiornamenti recenti sulla gestione

Here's Why Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) CEO May Have Their Pay Bumped Up

May 08
Here's Why Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) CEO May Have Their Pay Bumped Up

Recent updates

Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) Price Is Right But Growth Is Lacking After Shares Rocket 28%

Sep 18
Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) Price Is Right But Growth Is Lacking After Shares Rocket 28%

Investors Don't See Light At End Of Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) Tunnel

Jul 30
Investors Don't See Light At End Of Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) Tunnel

Here's Why Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) CEO May Have Their Pay Bumped Up

May 08
Here's Why Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) CEO May Have Their Pay Bumped Up

Benign Growth For Capricor Therapeutics, Inc. (NASDAQ:CAPR) Underpins Stock's 26% Plummet

Apr 19
Benign Growth For Capricor Therapeutics, Inc. (NASDAQ:CAPR) Underpins Stock's 26% Plummet

We're Not Very Worried About Capricor Therapeutics' (NASDAQ:CAPR) Cash Burn Rate

Apr 16
We're Not Very Worried About Capricor Therapeutics' (NASDAQ:CAPR) Cash Burn Rate

Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) 25% Dip In Price Shows Sentiment Is Matching Revenues

Feb 03
Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) 25% Dip In Price Shows Sentiment Is Matching Revenues

Is Capricor Therapeutics (NASDAQ:CAPR) In A Good Position To Invest In Growth?

Dec 13
Is Capricor Therapeutics (NASDAQ:CAPR) In A Good Position To Invest In Growth?

Here's Why We're Not Too Worried About Capricor Therapeutics' (NASDAQ:CAPR) Cash Burn Situation

Aug 13
Here's Why We're Not Too Worried About Capricor Therapeutics' (NASDAQ:CAPR) Cash Burn Situation

A Look At The Fair Value Of Capricor Therapeutics, Inc. (NASDAQ:CAPR)

Nov 03
A Look At The Fair Value Of Capricor Therapeutics, Inc. (NASDAQ:CAPR)

Capricor Therapeutics GAAP EPS of -$0.29 misses by $0.03

Aug 10

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Linda Marbán rispetto agli utili di Capricor Therapeutics?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2024n/an/a

-US$34m

Jun 30 2024n/an/a

-US$28m

Mar 31 2024n/an/a

-US$24m

Dec 31 2023US$747kUS$221k

-US$22m

Sep 30 2023n/an/a

-US$29m

Jun 30 2023n/an/a

-US$29m

Mar 31 2023n/an/a

-US$29m

Dec 31 2022US$1mUS$210k

-US$29m

Sep 30 2022n/an/a

-US$27m

Jun 30 2022n/an/a

-US$25m

Mar 31 2022n/an/a

-US$23m

Dec 31 2021US$2mUS$200k

-US$20m

Sep 30 2021n/an/a

-US$18m

Jun 30 2021n/an/a

-US$18m

Mar 31 2021n/an/a

-US$17m

Dec 31 2020US$2mUS$150k

-US$14m

Sep 30 2020n/an/a

-US$11m

Jun 30 2020n/an/a

-US$9m

Mar 31 2020n/an/a

-US$7m

Dec 31 2019US$229kUS$157k

-US$8m

Sep 30 2019n/an/a

-US$9m

Jun 30 2019n/an/a

-US$12m

Mar 31 2019n/an/a

-US$14m

Dec 31 2018US$377kUS$233k

-US$15m

Sep 30 2018n/an/a

US$374k

Jun 30 2018n/an/a

US$2m

Mar 31 2018n/an/a

US$2m

Dec 31 2017US$602kUS$233k

US$2m

Compensazione vs Mercato: La retribuzione totale di Linda ($USD 747.32K ) è inferiore alla media delle aziende di dimensioni simili nel mercato US ($USD 3.21M ).

Compensazione vs guadagni: La retribuzione di Linda è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

Linda Marbán (61 yo)

14.8yrs

Mandato

US$747,315

Compensazione

Dr. Linda Marbán, Ph.D. Co-founded Capricor Therapeutics, Inc. (also known as Capricor, Inc). in 2005 and also has been its Chief Executive Officer since 2010 and serves as its President. Dr. Marbán has be...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Frank Litvack
Executive Chairman of the Board12.8yrsUS$759.55k0.29%
$ 2.5m
Linda Marbán
Co-Founder14.8yrsUS$747.32k0.44%
$ 3.7m
Anthony Bergmann
CFO & Corporate Treasurer6.8yrsUS$730.85k0.0052%
$ 44.0k
Karen Krasney
Executive VP12.7yrsUS$740.77k0.044%
$ 370.1k
Kristi A. Elliott
Chief Science Officerno dataNessun datoNessun dato
Catherine Kelleher
Consultantno dataNessun datoNessun dato

12.7yrs

Durata media

64.5yo

Età media

Gestione esperta: Il team dirigenziale di CAPR è esperto e expertise (durata media dell'incarico 12.7 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Frank Litvack
Executive Chairman of the Board12.8yrsUS$759.55k0.29%
$ 2.5m
Linda Marbán
Co-Founder11yrsUS$747.32k0.44%
$ 3.7m
George Dunbar
Independent Director11yrsUS$211.13k0.023%
$ 194.9k
Earl Collier
Independent Director11yrsUS$222.37k0.13%
$ 1.0m
David Musket
Independent Director11yrsUS$237.36k0.20%
$ 1.6m
Francesco Muntoni
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Pat Furlong
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Eugenio Mercuri
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Craig McDonald
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Oscar Mayer
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Michelle Eagle
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Michael Taylor
Member of Scientific Advisory Board6.8yrsNessun datoNessun dato

11.0yrs

Durata media

68yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di CAPR è composto da personale esperto e esperto (durata media dell'incarico 11 anni).